药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Potassium cation
Alphacetylmethadol
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Alphacetylmethadol.
Potassium cation
Cloxazolam
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Cloxazolam.
Potassium cation
Dihydrocodeine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Dihydrocodeine.
Potassium cation
Drotebanol
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Drotebanol.
Potassium cation
Ethyl loflazepate
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Ethyl loflazepate.
Potassium cation
Flunitrazepam
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Flunitrazepam.
Potassium cation
Carfentanil
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Carfentanil.
Potassium cation
Chlorhexadol
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Chlorhexadol.
Potassium cation
Desomorphine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Desomorphine.
Potassium cation
Dextromoramide
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Dextromoramide.
Potassium cation
Delorazepam
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Delorazepam.
Potassium cation
Tenamfetamine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Tenamfetamine.
Potassium cation
Difenoxin
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Difenoxin.
Potassium cation
Etorphine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Etorphine.
Potassium cation
Dichloralphenazone
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Dichloralphenazone.
Potassium cation
Camazepam
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Camazepam.
Potassium cation
Dimethyltryptamine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Dimethyltryptamine.
Potassium cation
4-Bromo-2,5-dimethoxyamphetamine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with 4-Bromo-2,5-dimethoxyamphetamine.
Potassium cation
Barbital
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Barbital.
Potassium cation
4-Methoxyamphetamine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with 4-Methoxyamphetamine.